[Pyridinolcarbamate in diabetic angiopathies].
D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000378:metabolism; D001777:Blood Coagulation / Q000187:drug effects; D001920:Bradykinin / Q000037:antagonists & inhibitors; D002219:Carbamates / Q000494:pharmacology*; D003331:Coronary Vessels / Q000187:drug effects; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006023:Glycoproteins / Q000378:metabolism; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D010992:Plethysmography, Impedance; D011727:Pyridinolcarbamate / Q000494:pharmacology*; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects
D002219:Carbamates; D006023:Glycoproteins; D011727:Pyridinolcarbamate; D001920:Bradykinin
Il piridinolcarbamato nell'angiopatia diabetica.